Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.4.9 extracted from

  • Lee, L.S.; Cheng, Y.C.
    Human thymidylate kinase. Purification, characterization, and kinetic behavior of the thymidylate kinase derived from chronic myelocytic leukemia (1977), J. Biol. Chem., 252, 5686-5691.
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
ADP
-
Homo sapiens
dADP
-
Homo sapiens
dTDP
-
Homo sapiens
dTTP
-
Homo sapiens
thymidine 0.77 mM, 27% inhibition Homo sapiens

KM Value [mM]

KM Value [mM] KM Value Maximum [mM] Substrate Comment Organism Structure
0.13
-
dATP pH 7.2, 37°C Homo sapiens
0.25
-
ATP pH 7.2, 37°C Homo sapiens
0.33
-
GTP pH 7.2, 37°C Homo sapiens
0.45
-
dGTP pH 7.2, 37°C Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Purification (Commentary)

Purification (Comment) Organism
-
Homo sapiens

Source Tissue

Source Tissue Comment Organism Textmining
blast cell of chronic myelocytic leukemia Homo sapiens
-

Specific Activity [micromol/min/mg]

Specific Activity Minimum [µmol/min/mg] Specific Activity Maximum [µmol/min/mg] Comment Organism
0.809
-
-
Homo sapiens

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
dATP + dTMP dATP is as active as ATP Homo sapiens dADP + dTDP
-
?
dGTP + dTMP 42% of the activity with ATP Homo sapiens dGDP + dTDP
-
?
GTP + dTMP 38% of maximal activity Homo sapiens GDP + dTDP
-
?

Ki Value [mM]

Ki Value [mM] Ki Value maximum [mM] Inhibitor Comment Organism Structure
0.75
-
dTTP
-
Homo sapiens